CPHI receives NYSE American delisting notice for insufficient stockholders' equity

CHINA PHARMA HOLDINGS, INC.

Stockholders' equity was $5.3M as of March 31, 2022, below the $6.0M minimum required under Section 1003(a)(iii).
Company must submit a compliance plan by July 15, 2022 to regain compliance by December 15, 2023.
CPHI stock will continue trading on NYSE American under symbol CPHI with added '.BC' designation.
Failure to submit or comply with the plan may result in commencement of delisting proceedings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.